Jahnabi Arika

Title: Jahnabi Arika: Innovator in Protein Engineering

Introduction

Jahnabi Arika is a notable inventor based in Bengaluru, India. He has made significant contributions to the field of protein engineering, particularly in the development of therapeutic proteins. His innovative work focuses on modifying biological pathways to enhance protein functionality.

Latest Patents

Jahnabi Arika holds a patent for a "Non-fucosylated protein and methods thereof." This patent involves the development of cell lines where specific biological pathways are modified, particularly through changes in the enzymes of the cell. The technology enables the creation of protein expression systems that achieve specific modifications of glycan chains, resulting in non-fucosylated proteins, including non-fucosylated antibodies. These proteins are crucial for developing therapeutic monoclonal antibodies and biomarkers, as well as for diagnosing and prognosing various diseases. The patent employs Transcription Activator-like Effector Nuclease (TALEN) technology to inactivate fucosylation in cells.

Career Highlights

Jahnabi Arika is currently associated with Zumutor Biologics Inc., where he continues to advance his research in protein engineering. His work has the potential to impact the development of new therapeutic options in medicine.

Collaborations

Some of his notable coworkers include Sohang Chatterjee and Kavitha Iyer Rodrigues, who contribute to the innovative environment at Zumutor Biologics Inc.

Conclusion

Jahnabi Arika's contributions to the field of protein engineering exemplify the importance of innovation in developing therapeutic solutions. His patent on non-fucosylated proteins highlights the potential for advancements in medical diagnostics and treatment.